4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-060440
Director acquired 41,493 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Link David Charles Director | 2022-12-07 | Grant or award | +41,493 | $1.21 | $49,999 | 57,313 | D |
| Derivatives | |||||||
| Link David Charles Director | 2022-12-07 | Grant or award · Warrant (Common Stock) | +41,493 | 41,493 | D | ||
Loading xslF345X03/doc4.xml…